Bionor Pharma completes Solon Eiendom acquisition
Perspectivas América Latina 2023 Emerging Trends & Growth
Insight Weekly: SVB fallout limited; US rents up; renewable natural gas investments flow in
A Cloud Migration Plan for Corporations featuring Snowflake®
Investor Activism Campaigns Hit Record High in 2022
Bionor Pharma ASA completed its acquisition of Oslo-based residential property developer Solon Eiendom AS.
The deal is part of a broader restructuring under which Bionor Pharma plans to change its name to Solon Eiendom and transfer its HIV research activities to a subsidiary.
